Compass Minerals International (CMP) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
29 Jun, 2026Executive summary
Net income for Q2 2026 was $12.7 million, reversing a net loss of $32.0 million in Q2 2025, driven by higher gross profit, reduced SG&A expenses, and absence of impairment losses.
Adjusted EBITDA for Q2 2026 reached $86.4 million, up 3% year over year, with margins improving in both Salt and Plant Nutrition segments.
The company retired $150 million of senior unsecured notes due 2027, strengthening its balance sheet and reducing debt.
Completed new collective bargaining agreements at key sites, including Goderich Mine, enhancing operational flexibility.
Sale of Wynyard SOP business completed, resulting in a $14.6 million pre-tax loss and supporting balance sheet strengthening.
Financial highlights
Q2 2026 consolidated revenue was $453.2 million, down 8% year-over-year due to lower Salt segment sales volumes.
Adjusted EBITDA for Q2 2026 was $86.4 million, up from $84.1 million year-over-year, with margin improving to 19.1%.
Salt segment revenue was $382.6 million (down from $433 million); Plant Nutrition revenue was $67.0 million (up from $58 million).
Plant Nutrition adjusted EBITDA was $16.9 million, up 202% year-over-year, with margin rising to 25.2%.
Net income per diluted share was $0.30; adjusted net income per diluted share was $0.63.
Outlook and guidance
Full-year 2026 adjusted EBITDA guidance maintained at $212–$236 million.
Salt segment FY26 revenue guidance: $1,025–$1,080 million; adjusted EBITDA: $225–$240 million.
Plant Nutrition FY26 revenue guidance: $190–$210 million; adjusted EBITDA: $43–$47 million.
Capital expenditures for 2026 expected at $90–$110 million.
Effective income tax rate projected at 30%–34%.
Latest events from Compass Minerals International
- Net loss narrowed, Plant Nutrition margins rose, and full-year EBITDA guidance increased.CMP
Q3 2026 - All voting items passed and no stockholder questions were raised during the meeting.CMP
AGM 2026 - Q1 2026 net income hit $18.6M, EBITDA doubled, and guidance was raised on strong salt results.CMP
Q1 2026 - Shareholders will vote on directors, executive pay, and auditor, with a focus on governance and ESG.CMP
Proxy Filing - Key votes include director elections, executive pay, and auditor ratification for 2026.CMP
Proxy Filing - Net loss narrowed, debt fell, and 2026 guidance targets margin and EBITDA growth.CMP
Q4 2025 - 2024 net loss from impairments; 2025 outlook sees Salt volume growth and stable capex.CMP
Q4 2024 - Revenue up 36% to $494.6M, net loss narrowed, and Fortress exited amid cost actions.CMP
Q2 2025 - Q1 FY2025 revenue down 10%, net loss narrowed, and Plant Nutrition volumes rose.CMP
Q1 2025